Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NUVAXOVID XBB.1.5 DISPERSION INYECTABLE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/NUVAXOVID XBB.1.5 DISPERSION INYECTABLE

Approved

STANDARD

NUVAXOVID XBB.1.5 DISPERSION INYECTABLE

Sanofi Winthrop Industrie🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 20, 2023
Approval ID: 09be04df3a480db6
Company: Sanofi Winthrop Industrie
Type: Standard

Approval Details

Approval Id: 09be04df3a480db6
Drug Cima Aemps Name: NUVAXOVID XBB.1.5 DISPERSION INYECTABLE
Register Number: 1211618008
Holder Company Name: Sanofi Winthrop Industrie
Marketing Company Name: Sanofi Aventis S.A.
Holder Company Detail Path: /organization/sanofi-winthrop-industrie
Authorization Date: 2023-11-20
Dosage Form: DISPERSIÓN INYECTABLE
Dose: 5 MICROGRAMOS
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Sanofi Winthrop Industrie
Company Detail Path: /organization/sanofi-winthrop-industrie

Company Information

Pharmaceutical Company Name: SANOFI WINTHROP INDUSTRIE
Country Name: France
City Name: amilly,centre val de loire,country_fr
Address: 130 RUE DE LA FONTAINE

Active Ingredients

VACUNA DE PROTEINA RECOMBINANTE DE LA ESPICULA DE SARS-COV-2 (OMICRON XBB.1.5)(NOVAVAX)

5 µg/dosis

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 20, 2023

Approval ID

09be04df3a480db6

Type

Standard

Back to CIMA-AEMPS Approvals